SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nuvelo (Nasdaq: NUVO) -- Ignore unavailable to you. Want to Upgrade?

To: CharlieS who wrote (16)10/21/1997 2:47:00 PM
From: Boyce Burge  Read Replies (1) | Respond to of 286
 
Why can't this company get a web site so we can learn something more about them??

They appear to have adequate cash, about $60 million, and their burn rate is about $7 mil per year. Lots of partial sequences, and a cozy relationship with Chiron.

I'd like to see evidence that other big pharmas want to partner with Hyseq before I conclude that they have INCY or AFFX beating technology.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News